Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain

Masashi Morita(Kyoto University), So Hashizume(Chiba University), Masataka Sugimoto(National Center for Geriatrics and Gerontology), Atsushi Yasuda(National Institute of Health Sciences), Asato Kojima(National Institute of Health Sciences), Kota Suzuki(Kyoto University), H. Kobayashi(Chiba Cerebral and Cardiovascular Center), K. Kajima(Chiba Cerebral and Cardiovascular Center), Kazuhiko Watanabe(Chiba Cerebral and Cardiovascular Center)
Vaccine
March 1, 1987
Cited by 23


Related Papers